Call

AIRC Investigator Grant 2024

Grant agreement

No.31088

Starting date

1 January 2025

Ending date

31 December 2029

UniPD funding

789.000,00

Role

Principal Investigator

AIRC 2024


Deciphering phase separation and aggregation mechanisms driving von Hippel-Lindau tumor suppressor

Abstract

Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene lead to VHL disease, characterized by vascular tumors like clear cell carcinoma, hemangioblastoma, and pheochromocytoma. pVHL is an adaptor protein implicated in many biological processes promoting cell survival. Phase separation (PS) has become increasingly significant in comprehending the regulation of multiple signaling pathways within cells, playing a role in controlling the spatial and temporal aspects of cellular signaling events. Its dynamic and integrative nature makes it a critical mechanism for orchestrating complex cellular responses to internal and external cues. pVHL has emerged as a widely recognized model system for investigating the physiological significance of stress induced aggregation in determining cell fate and fostering tumor development.



Funded by AIRC, the Italian Association for Cancer Research